论文部分内容阅读
目的:检验肝硬化患者凝血四项指标,研究临床意义。方法:选取2013年9月-2014年9月本院住院肝硬化患者和同期本院体检中心健康体检合格者,肝硬化组患者和健康体检合格组人员分别为60例,利用法国Stago血凝仪对肝硬化患者和健康体检合格组人员的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原定量(FIB)含量进行测定。结果:肝硬化组患者的PT、APTT、TT指标明显比健康体检合格者高,而FIB明显低于健康体检合格者,两组比较,差异具有统计学意义(P<0.05)。结论:凝血四项检验结果能够反映肝硬化患者的凝血功能,对监测患者的病情、临床治疗有着重要的意义。
Objective: To examine the four indicators of coagulation in patients with cirrhosis and to study the clinical significance. Methods: From September 2013 to September 2014, hospitalized cirrhosis patients in our hospital and those in our hospital physical examination center during the same period were selected. The patients in the cirrhosis group and the health examination group were 60 and 74 respectively. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen quantitation (FIB) were determined in patients with cirrhosis and healthy subjects. Results: The indexes of PT, APTT and TT in patients with cirrhosis were significantly higher than those of healthy people and FIB was lower than that of healthy people. There was significant difference between the two groups (P <0.05). Conclusion: The results of the four tests of coagulation can reflect the coagulation function of patients with cirrhosis, which is of great significance for monitoring the patient’s condition and clinical treatment.